Last winter, for the first time since Covid-19 entered our world, influenza reclaimed its spot as the worst actor among the ...

Each year, as Americans roll up their sleeves for their annual flu shot, they might be surprised to learn their protection ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

The United States may be headed for a rough flu season, with a virus that causes more severe symptoms than the one last year ...

Trends complicating 2025 flu season include a new H3N2 variant, declining vaccination rates, and ongoing measles outbreaks impacting hospitals.

The U.S. is bracing for what is expected to be a severe flu season as a new strain is increasing cases globally ...

A mutated strain of influenza A, H3N2 subclade K, is surging worldwide, sparking concerns about a severe flu season in the ...

Merck said on Monday it expects a commercial opportunity exceeding $5 billion from Cidara Therapeutics' experimental flu drug ...